Priority dates, work visas, and labor market data
H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
National AverageGrowth
Growth 2008-2019 (Filing Volume)Top Employers
Hiring This Role| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH,INC. | 78 | $86,032 | $61,277 - $130,880 | 97.4% |
| GENENTECH | 61 | $91,718 | $62,000 - $135,456 | 96.7% |
| AMGEN INC. | 59 | $86,519 | $54,059 - $135,000 | 100.0% |
| REGENERON PHARMACEUTICALS, INC. | 48 | $83,088 | $53,544 - $137,000 | 93.8% |
| MEDIMMUNE, INC. | 46 | $78,865 | $56,976 - $121,188 | 84.8% |
| HISTOGENETICS LLC | 33 | $64,461 | $52,894 - $70,000 | 87.9% |
| UNIVERSITY OF MICHIGAN | 32 | $56,501 | $38,556 - $90,000 | 100.0% |
| UNIVERSITY OF UTAH | 24 | $46,100 | $37,794 - $76,000 | 87.5% |
| GILEAD SCIENCES, INC. | 23 | $91,962 | $62,795 - $118,630 | 100.0% |
| Millennium Pharmaceuticals, Inc. | 23 | $88,471 | $71,400 - $121,451 | 91.3% |
| ABBOTT LABORATORIES | 20 | $76,330 | $55,000 - $108,534 | 75.0% |
| Memorial Sloan Kettering Cancer Center | 20 | $60,596 | $47,502 - $84,178 | 100.0% |
| VERTEX PHARMACEUTICALS INCORPORATED | 17 | $88,792 | $62,000 - $126,090 | 100.0% |
| ILLUMINA | 16 | $79,512 | $54,746 - $135,000 | 93.8% |
| MERCK & CO., INC. | 14 | $84,578 | $66,934 - $105,549 | 92.9% |
| City | State | Filings | Median Salary |
|---|---|---|---|
| CAMBRIDGE | MA | 166 | $83,539 |
| SOUTH SAN FRANCISCO | CA | 64 | $90,348 |
| THOUSAND OAKS | CA | 54 | $86,947 |
| Cambridge | MA | 51 | $87,850 |
| TARRYTOWN | NY | 49 | $82,726 |
| NEW YORK | NY | 44 | $68,239 |
| GAITHERSBURG | MD | 41 | $76,974 |
| OSSINING | NY | 33 | $64,461 |
| SAN DIEGO | CA | 31 | $72,053 |
| ANN ARBOR | MI | 29 | $57,552 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| FY 2008 | 103 | $73,596 | 91.3% |
| FY 2010 | 190 | $71,515 | 96.8% |
| FY 2011 | 164 | $69,829 | 92.7% |
| FY 2012 | 153 | $69,661 | 95.4% |
| FY 2013 | 153 | $68,959 | 90.8% |
| FY 2014 | 190 | $70,553 | 91.1% |
| FY 2015 | 151 | $69,954 | 94.0% |
| FY 2016 | 204 | $74,161 | 94.1% |
| FY 2017 | 157 | $75,346 | 94.3% |
| FY 2018 | 184 | $75,844 | 98.4% |
| FY 2019 | 104 | $79,954 | 94.2% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH,INC. | 78 | $86,032 | 97.4% |
| GENENTECH | 61 | $91,718 | 96.7% |
| AMGEN INC. | 59 | $86,519 | 100.0% |
| REGENERON PHARMACEUTICALS, INC. | 48 | $83,088 | 93.8% |
| MEDIMMUNE, INC. | 46 | $78,865 | 84.8% |